NCPA: Access to controlled substances often delayed

January 16, 2014
NCPA: access to controlled substances often delayed

(HealthDay)—Most pharmacists report experiencing multiple delays or issues with their controlled substance orders, according to the results of the National Community Pharmacists Association (NCPA) Controlled Substances Access Survey.

Members of the NCPA were surveyed in December 2013 regarding pharmacy access to controlled . More than 1,000 responded to the survey, which included an open-ended section to share observations.

According to the report, in the past 18 months, about 75 percent of respondents experienced three or more delays or issues with their controlled substance orders, which were caused by stopped shipments. On average, these delays affected 55 patients per pharmacy. Most pharmacies (89 percent) received no advanced notice of the delay, and only discovered the delay when their order arrived and included only non-controlled substances. The delays in receiving these medications lasted at least a week for 60 percent of the respondents. The majority of pharmacists (67.9 percent) reported being unable to obtain these substances from an alternate source. As a result, most pharmacies had to turn patients away and refer them to a competitor.

"Vulnerable patients are increasingly and tragically becoming collateral damage in the country's battle against the abuse of prescription drugs, particularly ," Douglas Hoey, R.Ph., M.B.A., of the NCPA, said in a statement.

Explore further: Study finds doctor and pharmacy shopping are linked to prescription drug overdose deaths

More information: More Information

Related Stories

Recommended for you

Why kicking the opioid habit can be so tough

July 20, 2016

(HealthDay)—He was 26, a specialist fifth class with the U.S. Army, and stationed abroad, when an accident on the German autobahn sent him careening through the windshield of his car.

New research shows vaccine protection against Zika virus

June 28, 2016

The rapid development of a safe and effective vaccine to prevent the Zika virus (ZIKV) is a global priority, as infection in pregnant women has been shown to lead to fetal microcephaly and other major birth defects. The World ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.